What is Entropix?
Entropix is an enzyme engineering company focused on developing high-performance enzymes and biocatalysts through directed evolution. The company integrates advanced experimental molecular technology with computational methods, including protein engineering, gene sequence analysis, enzyme structure analysis, and machine learning. This approach allows them to identify novel connections between amino acid sequences and enzyme function.
Entropix aims to address challenges in various sectors such as diagnostics, life sciences, manufacturing, pharmaceuticals, and food ingredients by creating unique enzymes. In addition to enzyme development, they have innovated NADA™ and ALGO™, a proprietary technology designed for the efficient, solvent-free capture, recovery, and purification of nucleic acids, applicable in diagnostics, forensics, research, and recombinant protein production.
Features
- Directed Evolution: Utilizes directed evolution techniques to develop novel enzymes.
- Protein Engineering Platform: Combines experimental molecular technology and computational methods.
- AI-Driven Analysis: Employs machine learning and algorithmic computation for gene sequence and enzyme function analysis.
- NADA™ & ALGO™ Technology: Provides solvent-free capture, recovery, and purification of nucleic acids.
- Cross-Sector Application: Develops solutions for diagnostics, life science, manufacturing, pharmaceutical, and food ingredient industries.
Use Cases
- Developing novel biocatalysts for industrial manufacturing processes.
- Creating high-performance enzymes for diagnostic assays.
- Engineering enzymes for pharmaceutical development and production.
- Improving food ingredients through enzymatic modification.
- Purifying nucleic acids for molecular biology research.
- Capturing DNA/RNA for forensic analysis.
- Facilitating recombinant protein production workflows.
Related Queries
Helpful for people in the following professions
Featured Tools
Join Our Newsletter
Stay updated with the latest AI tools, news, and offers by subscribing to our weekly newsletter.